Metabolomics of Bladder Cancer: An Emerging Application offers insights into the latest research methodologies and potential therapeutic applications. The book examines how applied research on the discovery of metabolomic biomarkers with prognostic and predictive value is needed to stratify patients into different risk groups, minimizing overtreatment and the risk of drug resistance development. In eight chapters, the book gives an in-depth analysis of recent findings in both fundamental and applied research, with a focus on the metabolomics approach and its potential for identifying major metabolic pathways that characterize various diseases and physiological states. It intuitively leads from the discovery of biomarkers for bladder cancer, to the metabolisms of glutamine and fatty acids and finalizes with a chapter on the metabolic effect of cancer therapy. Overall, this book is a comprehensive and insightful resource for researchers, clinicians, and academic professionals interested in the latest developments in bladder cancer research.
1. Metabolomics of Bladder Cancer - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page ii 4. Table of Contents - p. Page iii 5. Copyright - p. Page iv 6. Contributors - p. Page iv 7. List of Illustrations - p. Page vi 8. List of Tables - p. Page vii 9. Chapter 1 : Contribution of metabolomics in the discovery of biomarker for urinary bladder cancer - p. Page vii 10. Chapter 2 : Role of tobacco on bladder cancer pathways - p. Page 8 11. Chapter 3 : Regulation of glycolysis in bladder cancer - p. Page 25 12. Chapter 4 : Metabolism of fatty acid - p. Page 47 13. Chapter 5 : Regulation of pentose phosphate pathway in bladder cancer - p. Page 65 14. Chapter 6 : Mitochondrial metabolism - p. Page 80 15. Chapter 7 : Metabolic effect of cancer therapy - p. Page 101 16. Chapter 8 : Metabolomics and racial disparities in bladder cancer carcinogenesis - p. Page 114 17. Index - p. Page 134
Metabolomics of Bladder Cancer: An Emerging Application offers insights into the latest research methodologies and potential therapeutic applications. The book examines how applied research on the discovery of metabolomic biomarkers with prognostic and predictive value is needed to stratify patients into different risk groups, minimizing overtreatment and the risk of drug resistance development. In eight chapters, the book gives an in-depth analysis of recent findings in both fundamental and applied research, with a focus on the metabolomics approach and its potential for identifying major metabolic pathways that characterize various diseases and physiological states. It intuitively leads from the discovery of biomarkers for bladder cancer, to the metabolisms of glutamine and fatty acids and finalizes with a chapter on the metabolic effect of cancer therapy. Overall, this book is a comprehensive and insightful resource for researchers, clinicians, and academic professionals interested in the latest developments in bladder cancer research.
1. Metabolomics of Bladder Cancer - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page ii 4. Table of Contents - p. Page iii 5. Copyright - p. Page iv 6. Contributors - p. Page iv 7. List of Illustrations - p. Page vi 8. List of Tables - p. Page vii 9. Chapter 1 : Contribution of metabolomics in the discovery of biomarker for urinary bladder cancer - p. Page vii 10. Chapter 2 : Role of tobacco on bladder cancer pathways - p. Page 8 11. Chapter 3 : Regulation of glycolysis in bladder cancer - p. Page 25 12. Chapter 4 : Metabolism of fatty acid - p. Page 47 13. Chapter 5 : Regulation of pentose phosphate pathway in bladder cancer - p. Page 65 14. Chapter 6 : Mitochondrial metabolism - p. Page 80 15. Chapter 7 : Metabolic effect of cancer therapy - p. Page 101 16. Chapter 8 : Metabolomics and racial disparities in bladder cancer carcinogenesis - p. Page 114 17. Index - p. Page 134
